According to RVL Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.1924. At the end of 2023 the company had a P/S ratio of 1.51.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.51 | -32.52% |
2022 | 2.23 | 0.42% |
2021 | 2.22 | 53.54% |
2020 | 1.45 | -4.05% |
2019 | 1.51 | -2.18% |
2018 | 1.54 |